Incyte (INCY) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free INCY Stock Alerts $51.68 +0.50 (+0.98%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Incyte Short Interest DataCurrent Short Volume8,270,000 sharesPrevious Short Volume8,060,000 sharesChange Vs. Previous Month+2.61%Dollar Volume Sold Short$441.87 millionShort Interest Ratio / Days to Cover4.8Last Record DateApril 15, 2024Outstanding Shares224,530,000 sharesPercentage of Shares Shorted3.68%Today's Trading Volume1,564,303 sharesAverage Trading Volume1,608,044 sharesToday's Volume Vs. Average97% Short Selling Incyte ? Sign up to receive the latest short interest report for Incyte and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINCY Short Interest Over TimeINCY Days to Cover Over TimeINCY Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Incyte Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20248,270,000 shares $441.87 million +2.6%N/A4.8 $53.43 3/31/20248,060,000 shares $459.18 million +1.9%N/A4.8 $56.97 3/15/20247,910,000 shares $461.71 million +1.8%N/A4.7 $58.37 2/29/20247,770,000 shares $453.46 million -10.7%N/A4.2 $58.36 2/15/20248,700,000 shares $513.04 million +24.6%N/A4.8 $58.97 1/31/20246,980,000 shares $410.21 million +33.5%N/A3.8 $58.77 Get the Latest News and Ratings for INCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Incyte and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,230,000 shares $328.13 million -17.1%N/A2.7 $62.74 12/31/20236,310,000 shares $396.20 million -9.5%N/A3.3 $62.79 12/15/20236,970,000 shares $434.23 million -15.7%N/A3.7 $62.30 11/30/20238,270,000 shares $449.39 million -10.7%N/A4.7 $54.34 11/15/20239,260,000 shares $509.11 million +1.8%N/A5.4 $54.98 10/31/20239,100,000 shares $490.76 million +13.2%N/A5.4 $53.93 10/15/20238,040,000 shares $463.18 million +7.3%N/A5 $57.61 9/30/20237,490,000 shares $432.70 million +15.6%N/A4.7 $57.77 9/15/20236,480,000 shares $405.32 million +13.5%N/A4.1 $62.55 8/31/20235,710,000 shares $368.47 million -4.0%N/A3.2 $64.53 8/15/20235,950,000 shares $389.19 million +21.4%N/A3.2 $65.41 7/31/20234,900,000 shares $312.23 million -14.5%N/A2.6 $63.72 7/15/20235,730,000 shares $353.88 million -3.4%N/A2.9 $61.76 6/30/20235,930,000 shares $369.14 million -7.1%N/A3 $62.25 6/15/20236,380,000 shares $399.26 million -7.1%2.9%3.2 $62.58 5/31/20236,870,000 shares $422.85 million -2.0%3.1%4.1 $61.55 5/15/20237,010,000 shares $464.06 million -5.9%3.2%4.4 $66.20 4/30/20237,450,000 shares $554.35 million -17.7%3.4%4.4 $74.41 4/15/20239,050,000 shares $674.23 million +9.8%N/A5.7 $74.50 3/31/20238,240,000 shares $595.50 million +26.2%N/A5.2 $72.27 3/15/20236,530,000 shares $473.23 million No ChangeN/A4 $72.47 2/28/20236,530,000 shares $502.68 million -3.1%N/A4 $76.98 2/15/20236,740,000 shares $534.82 million +14.0%N/A4.3 $79.35 1/31/20235,910,000 shares $503.18 million +33.7%N/A3.9 $85.14 1/15/20234,420,000 shares $357.27 million -10.3%N/A2.8 $80.83 12/30/20224,930,000 shares $395.98 million -11.8%N/A3.3 $80.32 12/15/20225,590,000 shares $459.67 million -13.2%N/A3.9 $82.23 11/30/20226,440,000 shares $513.07 million -8.5%N/A4.5 $79.67 11/15/20227,040,000 shares $539.40 million -15.9%N/A5 $76.62 10/31/20228,370,000 shares $622.23 million +2.2%N/A6.1 $74.34 10/15/20228,190,000 shares $565.93 million +3.2%N/A6.1 $69.10 9/30/20227,940,000 shares $529.12 million +9.5%N/A5.8 $66.64 9/15/20227,250,000 shares $500.11 million +7.9%N/A5.3 $68.98 8/31/20226,720,000 shares $473.29 million +3.5%N/A4.8 $70.43Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> INCY Short Interest - Frequently Asked Questions What is Incyte's current short interest? Short interest is the volume of Incyte shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 8,270,000 shares of INCY short. Learn More on Incyte's current short interest. What is a good short interest ratio for Incyte? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INCY shares currently have a short interest ratio of 5.0. Learn More on Incyte's short interest ratio. Which institutional investors are shorting Incyte? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Incyte: IMC Chicago LLC, Capital Fund Management S.A., Capstone Investment Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Incyte's short interest increasing or decreasing? Incyte saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 8,270,000 shares, an increase of 2.6% from the previous total of 8,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Incyte's short interest compare to its competitors? Here is how the short interest of companies compare to Incyte: Charles River Laboratories International, Inc. (3.71%), Medpace Holdings, Inc. (3.97%), Exelixis, Inc. (3.01%), National Research Co. (1.36%), ICON Public Limited (1.93%), IQVIA Holdings Inc. (1.58%), Exact Sciences Co. (5.45%), Insulet Co. (4.08%), DaVita Inc. (4.22%), Dr. Reddy's Laboratories Limited (0.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Incyte stock? Short selling INCY is an investing strategy that aims to generate trading profit from Incyte as its price is falling. INCY shares are trading up $0.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Incyte? A short squeeze for Incyte occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INCY, which in turn drives the price of the stock up even further. How often is Incyte's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INCY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Charles River Laboratories International Short Interest Data Medpace Short Interest Data Exelixis Short Interest Data National Research Short Interest Data ICON Public Short Interest Data IQVIA Short Interest Data Exact Sciences Short Interest Data Insulet Short Interest Data DaVita Short Interest Data Dr. Reddy's Laboratories Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INCY) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersYou Won't Believe Who Bezos is Working With to Fight Alzheimer'sBehind the MarketsThe #1 Crypto for 2024InvestorPlace